Myra, C., Sloper, L., Tighe, P.J., McIntosh, R.S., Stevens, S.E., Gregson, R.H., Sokal, M., Haynes, A.P. and Powell, R.J. (2004) Treatment of Erdheim-Chester Disease with Cladribine: A Rational Approach. British Journal of Ophthalmology, 88, 844-847.
https://doi.org/10.1136/bjo.2003.035584

has been cited by the following article:

• TITLE: Thirty-Four Months Control of Frail Patient with Multisystemic Affection Proved Erdheim Chester Disease: A Case Report

  AUTHORS: Emad Mohsen Barsoum, Fiby Samir Boules, May Gamal Ashour, Mohsen Samy Barsoum

  KEYWORDS: Erdheim-Chester Disease, Histiocytoses, Non-Langerhans Cell Histiocytoses

  JOURNAL NAME: Journal of Cancer Therapy, Vol.12 No.12, December 13, 2021

  ABSTRACT: Erdheim-Chester disease (ECD) is a rare non-Langerhans form of histiocytosis characterized by multisystemic involvement. We report a case of a 51-year-old male patient treated with pegylated IFN-α in a monthly schedule with low-dose prednisolone and achieved 34 months of control with minimal side effects.